Related Experiment Video
Updated: Jun 26, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Continuous venovenous hemodiafiltration trace element clearance in pediatric patients: a case series
Deborah A Pasko1, Mariann D Churchwell, Imad F Btaiche
1Department of Clinical, Social and Administrative Sciences, University of Michigan College of Pharmacy, 428 Church Street, Ann Arbor, MI 48109-1065, USA.
Insights
Continuous renal replacement therapy (CRRT) significantly clears minimal trace elements in critically ill children. Daily losses during continuous venovenous hemodiafiltration (CVVHDF) are less than standard supplementation.
Area of Science:
- Pediatric Nephrology
- Critical Care Medicine
- Trace Element Metabolism
Background:
- Continuous renal replacement therapy (CRRT) is essential for critically ill children with acute kidney injury.
- The impact of CRRT on trace element removal remains inadequately understood.
- This study quantifies trace element transmembrane clearance during continuous venovenous hemodiafiltration (CVVHDF).
Observation:
- Trace element concentrations (chromium, copper, manganese, selenium, zinc) were measured in pre-filter blood and effluent.
- Transmembrane clearance and daily losses of these elements were calculated in five pediatric patients undergoing CVVHDF.
- Clearance rates were normalized to body surface area per minute.
Findings:
- Median transmembrane clearance rates (per 1.73 m(2)/min) were: chromium 0 ml, copper 0.59 ml, manganese 2.48 ml, selenium 1.22 ml, and zinc 1.90 ml.
- Daily trace element losses via CVVHDF were substantially lower than standard pediatric parenteral nutrition supplementation for all measured elements.
- This suggests CRRT does not lead to significant depletion of these essential trace elements.
Implications:
- CRRT, specifically CVVHDF, demonstrates minimal clearance of key trace elements in pediatric patients.
- Current trace element supplementation in parenteral nutrition may be adequate, even during CVVHDF.
- Further research should confirm these findings and explore potential adjustments to supplementation protocols.
Abstract:
Continuous renal replacement therapy (CRRT) is used to treat critically ill children with acute kidney injury. The effect of CRRT on trace element clearance is poorly characterized. The purpose of this study was to quantify the transmembrane clearance of chromium, copper, manganese, selenium and zinc during continuous venovenous hemodiafiltration (CVVHDF). The transmembrane clearance of trace elements was assessed prospectively in five critically ill children receiving CVVHDF at the pediatric intensive care unit of a tertiary care university hospital. Pre-filter blood and effluent samples were measured for trace element concentrations. Transmembrane clearance of trace elements was calculated, and daily loss of each trace element was determined. Daily trace element loss via CVVHDF was compared with daily standard supplementation of trace elements in pediatric parenteral nutrition. Five patients (age range 23 months to 15 years) with a body weight range of 10.5-53 kg completed the study. The median transmembrane clearance of chromium, copper, manganese, selenium and zinc during CVVHDF was calculated as 0 ml, 0.59 ml, 2.48 ml, 1.22 ml, and 1.90 ml, respectively, per 1.73 m(2) body surface area per minute. The calculated CVVHDF losses were substantially smaller than the daily parenteral supplementation for all trace elements.
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
Hemodialysis II: Procedure and Complications
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Hemodialysis III: Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Excretion